He XR - Search Results

1

Marsdenia tenacissima extract overcomes Axl- and Met-mediated erlotinib and gefitinib cross-resistance in non-small cell lung cancer cells.

Han SY, Zhao W, Han HB, Sun H, Xue D, Jiao YN, He XR, Jiang ST, Li PP. Han SY, et al. Among authors: he xr. Oncotarget. 2017 May 24;8(34):56893-56905. doi: 10.18632/oncotarget.18137. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915640 Free PMC article.

2

Acupuncture and moxibustion for cancer-related fatigue: a systematic review and meta-analysis.

He XR, Wang Q, Li PP. He XR, et al. Asian Pac J Cancer Prev. 2013;14(5):3067-74. doi: 10.7314/apjcp.2013.14.5.3067. Asian Pac J Cancer Prev. 2013. PMID: 23803081 Free article. Review.

3

Corticosteroids for prevention of tuberculosis mortality.

He XR, Wang Q, Han SY, Li PP. He XR, et al. Lancet Infect Dis. 2013 Nov;13(11):916. doi: 10.1016/S1473-3099(13)70225-1. Lancet Infect Dis. 2013. PMID: 24156892 No abstract available.

4

Recent highlights of experimental research for inhibiting tumor growth by using Chinese medicine.

He XR, Han SY, Li PP. He XR, et al. Chin J Integr Med. 2015 Oct;21(10):727-32. doi: 10.1007/s11655-015-2318-8. Epub 2015 Nov 3. Chin J Integr Med. 2015. PMID: 26525545

5

Simultaneous determination of gefitinib and its major metabolites in mouse plasma by HPLC-MS/MS and its application to a pharmacokinetics study.

Zheng N, Zhao C, He XR, Jiang ST, Han SY, Xu GB, Li PP. Zheng N, et al. Among authors: he xr. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Feb 1;1011:215-22. doi: 10.1016/j.jchromb.2016.01.006. Epub 2016 Jan 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26795401

6

MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.

Han SY, Han HB, Tian XY, Sun H, Xue D, Zhao C, Jiang ST, He XR, Zheng WX, Wang J, Pang LN, Li XH, Li PP. Han SY, et al. Among authors: he xr. Oncotarget. 2016 Jul 5;7(27):42461-42473. doi: 10.18632/oncotarget.9886. Oncotarget. 2016. PMID: 27285759 Free PMC article.

7

Injectable Chinese herbal formula Kang'ai for nonsmall cell lung cancer: Trial sequential analysis of 2,259 participants from 31 randomized controlled trials.

He XR, Han SY, Li PP. He XR, et al. J Cancer Res Ther. 2016 Apr-Jun;12(2):735-43. doi: 10.4103/0973-1482.150411. J Cancer Res Ther. 2016. PMID: 27461643 Free article.

8

High-performance liquid chromatography coupled with tandem mass spectrometry technology in the analysis of Chinese Medicine Formulas: A bibliometric analysis (1997-2015).

He XR, Li CG, Zhu XS, Li YQ, Jarouche M, Bensoussan A, Li PP. He XR, et al. J Sep Sci. 2017 Jan;40(1):81-92. doi: 10.1002/jssc.201600784. Epub 2016 Nov 7. J Sep Sci. 2017. PMID: 27731929 Review.

9

Recent highlights of Chinese medicine for advanced lung cancer.

He XR, Han SY, Li PP. He XR, et al. Chin J Integr Med. 2017 May;23(5):323-330. doi: 10.1007/s11655-016-2736-2. Epub 2016 Dec 27. Chin J Integr Med. 2017. PMID: 28028718 Review.

10

Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.

He XR, Han SY, Li XH, Zheng WX, Pang LN, Jiang ST, Li PP. He XR, et al. J Ethnopharmacol. 2017 May 23;204:45-57. doi: 10.1016/j.jep.2017.04.008. Epub 2017 Apr 12. J Ethnopharmacol. 2017. PMID: 28412214

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters